ICD-10-CM Billable Code

A71.1

Active stage of trachoma

Clinical Classification Guidelines

Inclusion Terms

  • Granular conjunctivitis (trachomatous)
  • Trachomatous follicular conjunctivitis
  • Trachomatous pannus

Medical Intelligence & Overview

A71.1 refers to the active stage of trachoma, a contagious bacterial infection primarily affecting the eyes. This condition is characterized by inflammation of the conjunctiva, the transparent membrane covering the white part of the eye, and can lead to serious visual impairment if left untreated. Recognized as a significant public health concern in many parts of the world, trachoma is caused by infection with the bacterium *Chlamydia trachomatis*. This article provides an overview of the causes, symptoms, diagnosis, and available treatments for the active stage of trachoma, aiming to educate patients and caregivers.

Causes & Symptoms

Clinical Causes: Infection with *Chlamydia trachomatis*, transmitted through close personal contact, such as sharing towels or facial contact. Poor hygiene practices and living conditions that facilitate transmission. Inadequate access to clean water and sanitation facilities. Environmental factors like dust and flies, which can carry the bacteria to the eyes.

Key Symptoms: Redness and inflammation of the conjunctiva, often marked as granular or follicular conjunctivitis. Swelling of the eyelids (eyelid edema). Discharge from the eyes, which can be mucous or pus-like. Itching or irritation around the eyes. Foreign body sensation or feeling like there’s grit in the eyes. Progressing to pannus formation, where abnormal blood vessels grow over the cornea. Potential eye pain or sensitivity to light as the condition advances.

Diagnostic & Treatment

Diagnosis Path: Diagnosing trachoma involves a detailed eye examination by a healthcare professional, who looks for characteristic signs such as follicular conjunctivitis, pannus formation, or scarring. The presence of follicles (small lymphoid tissue projections) on the conjunctiva and signs of inflammation are key clues. In some cases, laboratory tests or examinations of eye secretions may be performed to confirm the presence of *Chlamydia trachomatis* bacteria. The WHO simplified trachoma grading system is commonly used to assess the severity and guide management.

Treatment Protocols: Treatment approaches focus on eradicating the infection and managing inflammation to prevent further complications. Common interventions include: - Antibiotic therapy: Topical antibiotics like tetracycline ointment or oral antibiotics such as azithromycin are prescribed to eliminate bacterial infection. - Improved hygiene practices: Regular face washing, reducing eyelid rubbing, and maintaining cleanliness help reduce spread. - Environmental improvements: Enhancing access to clean water, sanitation, and reducing fly populations can lower transmission rates. - Surgical intervention: In cases where eyelid scarring causes eyelid deformities leading to more serious eye issues, surgeries like bilamellar tarsal rotation (raws) may be necessary. Early detection and treatment are vital to prevent progression to more advanced, blinding stages of trachoma, such as trichiasis, where eyelashes turn inward and irritate the cornea.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is A71.1 a billable ICD-10 code?
Yes, A71.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report A71.1?
Clinical documentation must specify the nature of Active stage of trachoma and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

active trachoma stage